Biontech

AstraZeneca's vaccine effectiveness against COIVD-19 lasts longer than Pfizer's finds study

Pfizer had "greater initial effectiveness" but saw "faster declines in protection against high viral burden and symptomatic infection."

Pfizer-BioNtech submit data to health authorities for approval of third COVID-19 vaccine

The companies plan to submit the same information to European authorities in the coming weeks.

Delta variant cases mark 32% weekly increase in UK COVID figures, vaccine protection high, say officials

Overall, the Delta variant first identified in India currently accounts for approximately 99 percent of cases that are sequenced across the UK, followed by the local Alpha variant of concern

BioNTech founders to contribute to book documenting how they developed first COVID-19 vaccine

Drs Sahin and Türeci will explain the 30 years of scientific research that laid the foundations for the first COVID-19 vaccine, the publisher St Martin’s said.

Tokyo Olympics 2020: Britain yet to decide on Pfizer offer to vaccinate Japan-bound Olympians

Belgium, France, Germany, Italy and Spain are among the European nations to have already offered vaccines to delegations headed to Tokyo.

Tokyo Olympics 2020: Paralympics chief Andrew Parsons says chances of athletes spreading COVID-19 'remote'

As the Games approach, Japan is battling a fourth virus wave and public opinion remains firmly opposed to hosting them this summer.

Tokyo Olympics 2020: Pfizer, BioNTech to donate vaccines for athletes and officials, confirms IOC

The Pfizer donation followed talks between the firm’s chairman and CEO, Albert Bourla, and Japanese Prime Minister Yoshihide Suga.

Hong Kong, Macau suspend use of Pfizer-BioNTech COVID-19 vaccine over defective lids

Hong Kong govt has said the suspension was immediate while the matter is investigated by distributor Fosun Pharma and BioNTech, the German company that created the vaccine with American pharmaceutical firm Pfizer

Asian, African nations urge vaccine makers to share blueprints, COVID-19 vaccine know-how

Companies traditionally pour huge amounts of money and research into drugs and vaccines, for the right to profit from them.

Pfizer COVID-19 shot shines in 'real world' test, prevents severe disease across age groups

The vaccine was found 92 percent effective at preventing severe disease after two shots and 62 percent after one.